UCB Pharma
UCB is a global biopharmaceutical company that discovers, develops, and commercializes medicines for serious neurological and immunological diseases. Its portfolio includes epilepsy therapies such as Keppra and Briviact, Cimzia for inflammatory conditions, and Bimzelx for psoriasis, sold through healthcare providers and payers. Founded in 1928 and headquartered in Brussels, it operates worldwide with manufacturing and quality operations, including a site in Saitama, Japan.
Open Positions at UCB Pharma
1 open position
Lead hands-on technology initiatives embedded with business teams, turning ambiguous problems into prototypes, integrations, workflows, and production-ready AI-powered solutions. This Brussels-based role bridges business transformation, engineering, and enterprise technology strategy.